This session will look at the Early Phase Team's decision-making processes, use of adaptive designs to facilitate studies, and reduction of study times. An integrated approach with the aim to facilitate rapid development go/no-go decisions.

Learning Objectives:
Analyze the decision making processes used to determine Early Phase Drug Development with study designs to facilitate drug development go/no-go decisions
Identify strategies to facilitate the acceleration of studies from the volunteer phase into patients for proof-of-concept.